ABSTRACT
Introducción: La fibrilación auricular es la arritmia recurrente más habitual en la práctica clínica. Su prevalencia se multiplica en la población actual y tiene diferentes causas fisiopatológicas que la convierten en una pandemia mundial. Objetivos: Diseñar un modelo predictivo de fracaso de la terapia eléctrica en pacientes con fibrilación auricular paroxística. Métodos: Se realizó un estudio de casos y controles, con 33 casos y 66 controles. Variables predictoras: edad, fracción de eyección ≤ 40 por ciento, volumen de aurícula izquierda ≥ 34 mL/m2. A partir de la regresión logística se obtuvo un modelo en el que fueron incluidos el valor predictivo positivo, valor predictivo negativo, la sensibilidad y especificidad. Resultados: Los factores de riesgo predictores fueron: edad ≥ 55 años (p= 0,013; odds ratio (OR)= 3,58; intervalo de confianza -IC- 95 por ciento: 1,33-9,67); la fracción de eyección del ventrículo izquierdo (FEVI) ≤ 40 por ciento se observó en 20 pacientes (22,7 por ciento) (p= 0,004; OR= 4,45; IC95 por ciento: 1,54-12,8); presión de aurícula izquierda elevada, volumen de aurícula izquierda elevado (p= 0,004; OR= 3,11; IC95 por ciento: 1,24-8,77), según el modelo de regresión logística. Se realizó la validación interna por división de datos; se confirmó que el modelo pronostica bien los que van a tener éxito en el resultado terapéutico. Conclusiones: El modelo predictivo elaborado está compuesto por los predictores edad > 55 años, FEVI; volumen de aurícula izquierda; presenta un buen ajuste y poder discriminante, sobre todo valor predictivo positivo(AU)
Introduction: Atrial fibrillation is the most common recurrent arrhythmia in clinical practice. Its prevalence is multiplying in the current population and has different pathophysiological causes that make it a global pandemic. Objectives: To design a predictive model for failure of electrical therapy in patients with paroxysmal atrial fibrillation. Methods: A case-control study was carried out with 33 cases, and 66 controls. Predictor variables: age, ejection fraction ≤ 40 percent, left atrial volume ≥ 34 mL/m2. From logistic regression, a model was obtained in which the positive predictive value, negative predictive value, sensitivity and specificity were included. Results: The predictive risk factors were: age ≥ 55 years (p= 0.013; odds ratio (OR)= 3.58; 95 percent confidence interval -CI-: 1.33-9.67); left ventricular ejection fraction (LVEF) ≤ 40 percent was observed in 20 patients (22.7 percent) (p= 0.004; OR= 4.45; 95 percent CI: 1.54-12.8); elevated left atrial pressure, elevated left atrial volume (p= 0.004; OR= 3.11; 95 percent CI: 1.24-8.77), according to the logistic regression model. Internal validation was carried out by data division; It was confirmed that the model predicts very well those who will be successful in the therapeutic result. Conclusions: The predictive model developed is composed of the predictors age > 55 years, LVEF; left atrial volume; It presents a good fit and discriminating power, especially positive predictive value(AU)
Subject(s)
Humans , Male , Middle Aged , Atrial Fibrillation/diagnosis , Electric Countershock/methods , Electric Stimulation Therapy/methods , Forecasting/methods , Case-Control Studies , Mathematics/methodsABSTRACT
OBJECTIVE@#To analyze the clinical characteristics of patients with emergency in-hospital cardiac arrest (IHCA) in Kashgar, Xinjiang Uygur Autonomous Region and the factors affecting the success rate of cardiopulmonary resuscitation.@*METHODS@#Retrospectively selected patients who had cardiac arrest and cardiopulmonary resuscitation in the emergency department of the People's Hospital of 6 counties and cities in Kashgar area from January 2019 to January 2022. The clinical data of all patients were collected, including gender, age, major underlying diseases, the beginning and duration of resuscitation, the number of electric defibrillation acute physiology and chronic health evaluation II (APACHE II). According to whether the resuscitation was successful, all patients were divided into successful resuscitation group and failed resuscitation group. The clinical characteristics of the two groups were compared. Then, the influencing factors of the success rate of cardiopulmonary resuscitation in IHCA patients were analyzed by binary Logistic regression.@*RESULTS@#A total of 1 376 patients were enrolled, including 1 117 cases of failed resuscitation and 259 cases of successful resuscitation. The success rate of resuscitation was 18.82%. Compared with the resuscitation failure group, the patients in the successful resuscitation group were younger (age: 49.10±20.99 vs. 58.44±18.32), the resuscitation start time was earlier [resuscitation start time ≤ 5 minutes: 76.45% (198/259) vs. 66.61% (744/1 117)], the proportion of cardiovascular and cerebrovascular diseases was lower [cardiovascular disease: 49.42% (128/259) vs. 58.19% (650/1 117), cerebrovascular disease: 17.37% (45/259) vs. 21.58% (241/1 117)], the number of electric defibrillation was lower [times: 0 (0, 2) vs. 1 (0, 1)], the proportion of endotracheal intubation was more [80.31% (208/259) vs. 55.60% (621/1 117)], APACHE II score was lower (13.75±8.03 vs. 17.90±4.63), and the difference was statistically significant (all P < 0.01). Binary Logistic regression analysis showed that age, start time of resuscitation, ventilation mode and APACHE II score were protective factors affecting the success rate of cardiopulmonary resuscitation in patients with emergency IHCA [age: odds ratio (OR) = 0.982, 95% confidence interval (95%CI) was 0.973-0.991, P < 0.001; resuscitation start time ≤ 5 minutes: OR = 0.629, 95%CI was 0.409-0.966, P = 0.034; tracheal intubation assisted ventilation: OR = 0.243, 95%CI was 0.149-0.397, P < 0.001; low APACHE II score: OR = 0.871, 95%CI was 0.836-0.907, P < 0.001], while underlying diseases (cardiovascular diseases) are a risk factor affecting the success rate of cardiopulmonary resuscitation (OR = 1.190, 95%CI was 1.015-1.395, P = 0.036).@*CONCLUSIONS@#Age, resuscitation start time, ventilation mode, APACHE II score and major underlying diseases (cardiovascular diseases) have a greater impact on the success rate of resuscitation in IHCA patients. The above factors are conducive to improving or formulating more effective rescue strategies for IHCA patients, so as to achieve the purpose of improving the success rate of clinical treatment.
Subject(s)
Humans , Adult , Middle Aged , Aged , Retrospective Studies , Cardiopulmonary Resuscitation , Heart Arrest/therapy , Electric Countershock , HospitalsABSTRACT
RESUMO Objetivo construir, validar e avaliar vídeo educativo para estudantes de enfermagem sobre a parada cardiorrespiratória obstétrica. Método estudo metodológico, composto pela construção do vídeo, validação de conteúdo por 22 especialistas em parada cardiorrespiratória obstétrica e avaliação por 21 estudantes de graduação em enfermagem. Utilizou-se o Instrumento de Validação de Conteúdo Educacional em Saúde, para validação com os especialistas, e o questionário adaptado do Suitability Assessment of Materials, para avaliação dos estudantes. Na validação com juízes e com o público-alvo, foi considerado válido o item com concordância mínima de 80%, obtida a partir do Índice de Validação de Conteúdo e do Teste Binomial. Resultados o vídeo, com duração de 8 minutos e 53 segundos, contemplou as etapas da assistência de enfermagem na realização do suporte básico de vida à gestante acometida por parada cardiorrespiratória. Na validação de conteúdo, dos 18 itens avaliados, 16 tiveram concordância de 100%, um obteve 95% e o item restante obteve 81%. Na avaliação dos estudantes, dos 13 itens avaliados, 12 possuíram concordância de 100% e o item restante possuiu 95%. Conclusão e implicações para a prática o vídeo foi considerado válido pelos especialistas em parada cardiorrespiratória obstétrica e compreensível pelos estudantes de enfermagem, assim, trata-se de recurso educativo viável para contribuir com a formação da enfermagem.
RESUMEN Objetivo construir, validar y evaluar videos educativos para estudiantes de enfermería sobre parada cardiopulmonar obstétrica. Método estudio metodológico, consistente en la construcción del video, validación de contenido por 22 expertos en parada cardiorrespiratoria obstétrica y evaluación por 21 estudiantes de enfermería. Se utilizó el Instrumento de Validación de Contenidos Educativos en Salud, para la validación con los expertos, y el cuestionario adaptado del Suitability Assessment of Materials, para la evaluación de los estudiantes. En la validación con jueces y público objetivo, se consideró válido el ítem con una concordancia mínima del 80%, obtenido del Índice de Validación de Contenido y la Prueba Binomial. Resultados el video, de 8 minutos y 53 segundos, contempló los pasos del cuidado de enfermería en la realización de soporte vital básico a gestantes afectadas por paro cardíaco. En la validación de contenido, de los 18 ítems evaluados, 16 tuvieron un 100% de concordancia, uno tuvo un 95% y el restante un 81%. En la evaluación de los estudiantes, de los 13 ítems evaluados, 12 tuvieron un 100% de concordancia, y el ítem restante tuvo un 95%. Conclusión e implicaciones para la práctica el video fue considerado válido por especialistas en parada cardiopulmonar obstétrica y comprensible por estudiantes de enfermería, por lo que es un recurso educativo viable para contribuir a la formación en enfermería.
ABSTRACT Objective to construct, validate and assess educational video for nursing students about obstetric cardiopulmonary arrest. Method this is a methodological study consisting of video construction, content validation by 22 experts in obstetric cardiopulmonary arrest and assessment by 21 undergraduate nursing students. The Health Educational Content Validation Instrument was used for validation with experts, and a questionnaire adapted from the Suitability Assessment of Materials, for student assessment. In the validation with judges and the target audience, the item with a minimum agreement of 80% was considered valid, obtained from the Content Validation Index and the binomial test, was considered valid. Results video, lasting 8 minutes and 53 seconds, contemplated nursing care stages in carrying out basic life support to pregnant women affected by cardiac arrest. In content validation, of the 18 items assessed, 16 had 100% agreement, one had 95% and the remaining item had 81%. In students' assessment, of the 13 items assessed, 12 had 100% agreement, and the remaining item had 95%. Conclusion and implications for practice the video was considered valid by experts in obstetric cardiopulmonary arrest and understandable by nursing students, thus it is a viable educational resource to contribute to nursing education.
Subject(s)
Humans , Male , Female , Audiovisual Aids , Pregnancy , Cardiopulmonary Resuscitation/education , Education, Nursing/methods , Heart Arrest/nursing , Students, Nursing , Electric Countershock/nursing , Cesarean Section/nursing , Cardiopulmonary Resuscitation/nursing , Pregnant Women , MethodsABSTRACT
Abstract Mechanical ventilation in prone position is an alternative strategy for patients with acute respiratory discomfort syndrome (ARDS) to improve oxygenation in situations when traditional ventilation modalities have failed. However, due to the significant increase in ARDS cases during the SARS-CoV-2 pandemic and the experimental therapeutic use of potentially arrhythmogenic drugs, cardiopulmonary resuscitation in this unusual position could be needed. Therefore, we will review the available scientific evidence of cardiopulmonary resuscitation in prone position.
Subject(s)
Humans , Prone Position , Cardiopulmonary Resuscitation/methods , Respiration, Artificial/methods , Respiratory Distress Syndrome, Newborn/therapy , Electric Countershock/methods , Cardiopulmonary Resuscitation/instrumentationABSTRACT
Abstract Inappropriate therapy due to noise oversensing caused a true ventricular fibrillation (VF) and a life-threatening event in a patient. A 19-year-old patient with surgically corrected congenital heart disease and systolic dysfunction had an implantable cardioverter defibrillator implanted for primary prevention in 2013. This patient was admitted at the Emergency Department in June 2018 after receiving eight shocks from the device on the same day, with a prolonged syncope after the third shock. Another noise-induced VF detection occurred, and two inappropriate shocks followed sequentially, causing true VF. Four appropriate shocks were subsequently needed until sinus rhythm was finally restored.
Subject(s)
Humans , Defibrillators, Implantable , Arrhythmias, Cardiac , Electric CountershockABSTRACT
Resumen Introducción: El flutter auricular es un tipo poco frecuente de arritmia fetal y neonatal. A pesar de que puede conducir a graves morbilidades, como hidrops fetal o incluso el fallecimiento, el diagnóstico y tratamiento precoz confieren un buen pronóstico a la mayoría de los casos. Pacientes y métodos: Se presentan tres casos de flutter auricular, dos de inicio en periodo fetal y uno en periodo neonatal, y se revisa la literatura en relación con las características clínicas, diagnósticas y terapéuticas del flutter auricular fetal y neonatal. Resultados y discusión: En el flutter auricular fetal la terapia materna con fármacos antiarrítmicos es el tratamiento más empleado durante la gestación. El tratamiento postnatal más utilizado es la cardioversión eléctrica sincronizada. El flutter auricular no suele asociar cardiopatía estructural; la recidiva neonatal es poco habitual y normalmente no precisa la administración de tratamiento profiláctico.
Abstract Introduction: Atrial flutter is a rare type of fetal and neonatal arrhythmia. Although it can lead to serious morbidities such as fetal hydrops or even death, diagnosis and early treatment confer a good prognosis in most cases. Patients and methods: Three cases of atrial flutter are presented, two of which start in the fetal period and one in the neonatal period. The literature is reviewed in relation to the clinical, diagnostic and therapeutic characteristics of fetal and neonatal atrial flutter. Results and discussion: In fetal atrial flutter maternal therapy with antiarrhythmic drugs is the most used treatment during pregnancy. The most used postnatal treatment is synchronized electrical cardioversion. Atrial flutter does not usually associate structural heart disease, neonatal recurrence is uncommon and usually does not require prophylactic treatment.
Subject(s)
Humans , Male , Female , Infant, Newborn , Atrial Flutter , Recurrence , Electric Countershock , Hydrops Fetalis , Anti-Arrhythmia AgentsABSTRACT
A cardiomiopatia arritmogênica do ventrículo direito é uma desordem hereditária caracterizada pela substituição fibrogordurosa do músculo cardíaco. O manejo clínico busca reduzir os riscos de morte súbita e melhorar a qualidade de vida, aliviando os sintomas arrítmicos e de insuficiência cardíaca. O ecocardiograma é o exame inicial para a investigação da cardiomiopatia arritmogênica do ventrículo direito, podendo apresentar dilatação das câmaras direitas e disfunção sistólica do ventrículo direito. Este relato chama atenção por envolver o diagnóstico de cardiomiopatia arritmogênica do ventrículo direito em paciente atleta. Mulher, 47 anos, maratonista, sem história familiar de morte súbita cardíaca, deu entrada na emergência com palpitação associada à pré-síncope. O eletrocardiograma da admissão mostrava taquicardia ventricular. O ecocardiograma revelou aumento de câmaras cardíacas direitas e disfunção sistólica do ventrículo direito. O cateterismo cardíaco não evidenciou doença coronária obstrutiva. A paciente foi orientada acerca da necessidade de suspensão de atividades físicas, porém, 3 meses depois, foi readmitida com instabilidade hemodinâmica por nova taquicardia ventricular, tendo sido cardiovertida. Realizou ressonância cardíaca, que evidenciou áreas de discinesia e formação de microaneurismas em ventrículo direito. Foi diagnosticada com cardiomiopatia arritmogênica do ventrículo direito, tendo sido com cardioversor desfibrilador implantável, amiodarona e betabloqueador. A diferenciação entre a cardiomiopatia arritmogênica do ventrículo direito e o coração do atleta representa um desafio, devido à sobreposição de alterações estruturais que coexistem nessas entidades, daí a importância da análise integrada de fatores clínicos, eletrocardiográficos e morfofuncionais.(AU)
Subject(s)
Humans , Female , Middle Aged , Death, Sudden, Cardiac , Tachycardia, Ventricular/diagnosis , Arrhythmogenic Right Ventricular Dysplasia/genetics , Arrhythmogenic Right Ventricular Dysplasia/mortality , Heart Failure , Genetic Diseases, Inborn , Electric Countershock/methods , Echocardiography/methods , Magnetic Resonance Spectroscopy/methods , Electrocardiography, Ambulatory/methods , Heart Transplantation/methods , Defibrillators, Implantable , Catheter Ablation/methods , Electrocardiography/methods , Amiodarone/administration & dosage , Anti-Arrhythmia Agents/therapeutic useSubject(s)
Humans , Male , Middle Aged , Pulmonary Eosinophilia/diagnosis , Cor Triatriatum/genetics , Heart Defects, Congenital/diagnosis , Electric Countershock/methods , Echocardiography/methods , Magnetic Resonance Spectroscopy/methods , Catheter Ablation/methods , Echocardiography, Transesophageal/methods , Digoxin/administration & dosage , Electrocardiography/methods , Anticoagulants/administration & dosageABSTRACT
Abstract Sudden cardiac death (SCD) remains a major public health problem. Fortunately, with timely access to early defibrillation and high-quality cardiopulmonary resuscitation, an improvement in survival of victims of sudden death has been demonstrated. Efforts made in different countries to create programs for access to public defibrillation have shown great benefits in counteracting mortality associated with this type of event. Hence, we need more programs (such as cardio protected environments) and changes in public health policies. The objective of this work is to raise awareness among the population and decision makers, of importance establishing this type of programs in our country since there continues to be high mortality associated with SCD in our countrymen.
Resumen La muerte súbita cardíaca es todavía un problema importante de salud pública. Por fortuna, con un acceso oportuno a una desfibrilación temprana y una reanimación cardiopulmonar de alta calidad, se ha demostrado una mejoría en la sobrevida de las víctimas de muerte súbita. Los esfuerzos realizados en deferentes países para crear programas de acceso a la desfibrilación pública han mostrado grandes beneficios en contrarrestar la mortalidad relacionada con este tipo de episodios. Se necesitan más programas (como espacios cardioprotegidos) y cambios en las políticas de salud pública. El objetivo de este trabajo es poder concientizar a la población y a los tomadores de decisiones de la importancia de establecer este tipo de programas en el país, ya que aún existe una alta mortalidad relacionada con la muerte cardíaca súbita.
Subject(s)
Humans , Death, Sudden, Cardiac/prevention & control , Cardiopulmonary Resuscitation/methods , Electric Countershock , Public Health , Health Policy , Health Services Accessibility , MexicoABSTRACT
Abstract Atrial fibrillation (AF) is a frequent arrhythmia; its prevalence is near 2% in the general population; in Mexico, more than one-half million people are affected. AF needs to be considered as a public health problem. Because AF is an independent risk factor associated with mortality, due to embolic events, heart failure, or sudden death; early diagnosis is of utmost importance. In unstable patients with a recent onset of AF, electrical cardioversion should be practiced. In stable patients, once thromboembolic measures have been taken, it is necessary to assess whether it is reasonable to administer an antiarrhythmic drug to restore sinus rhythm or performed electrical cardioversion. For recidivating cases of paroxysmal and persistent presentation, the most effective strategy is performed pulmonary vein isolation with either radiofrequency or cryoballoon energy. Permanent AF is that in which recovery of sinus rhythm is not possible, the distinguishing feature of this phase is the uncontrollable variability of the ventricular frequency and could be treated pharmacologically with atrioventricular (AV) nodal blockers or with a VVIR pacemaker plus AV nodal ablation. The presence of AF has long been associated with the development of cerebral and systemic (pulmonary, limb, coronary, renal, and visceral) embolism. The prevention of embolisms in valvular AF should perform with Vitamin K antagonists (VKA). For patients with AF not associated with mitral stenosis or a mechanical valve prosthesis, a choice can be made between anticoagulant drugs, VKA, or direct oral anticoagulants. Antiplatelet agents have the weakest effect in preventing embolism.
Resumen La fibrilación auricular (FA) es una arritmia frecuente; su prevalencia es cercana al 2% en la población general, en México se ven afectados más de medio millón de personas por eso debe considerarse como un problema de salud pública. Debido a que la FA es un factor de riesgo independiente asociado a mortalidad, por eventos embólicos, insuficiencia cardíaca o muerte súbita, la identificación y diagnóstico temprano es de suma importancia. En el inicio reciente de FA en pacientes inestables, se debe practicar la cardioversión eléctrica. En pacientes estables, una vez que se han tomado medidas tromboembólicas, es necesario evaluar si es razonable administrar un medicamento antiarrítmico para restaurar el ritmo sinusal o realizar una cardioversión eléctrica. Para los casos que recidivan, ya sea paroxística o persistente, la estrategia más efectiva es realizar el aislamiento de la venas pulmonares con radiofrecuencia o crioablación con balón. La FA permanente es aquella en la que no es posible la recuperación del ritmo sinusal, la característica distintiva de esta fase de la FA es la variabilidad incontrolable de la frecuencia ventricular. Puede tratarse farmacológicamente con bloqueadores nodales AV o con un marcapasos VVIR mas ablación del nodo AV. La presencia de FA se ha asociado durante mucho tiempo con el desarrollo de embolia cerebral y sistémica (pulmonar, de extremidades, coronaria, renal y visceral). La prevención de embolias en la FA valvular debe realizarse con antagonistas de la vitamina K (AVK). Para los pacientes con FA no asociados con estenosis mitral o una prótesis valvular mecánica, se puede elegir entre medicamentos anticoagulantes, AVK o anticoagulantes orales directos (DOAC). Los agentes antiplaquetarios tienen el efecto más débil para prevenir la embolia.
Subject(s)
Humans , Atrial Fibrillation/therapy , Thromboembolism/prevention & control , Anticoagulants/administration & dosage , Atrial Fibrillation/complications , Atrial Fibrillation/epidemiology , Thromboembolism/etiology , Electric Countershock/methods , Risk Factors , Cryosurgery/methods , Fibrinolytic Agents/administration & dosage , Radiofrequency Ablation/methods , Mexico/epidemiology , Anti-Arrhythmia Agents/administration & dosageABSTRACT
Abstract Introduction: Atrial fibrillation (AF) is the most common chronic arrhythmia in the elderly population. In symptomatic patients, restoration and maintenance of sinus rhythm improve quality of life. Unfortunately, AF recurrence still occurs in a considerable number of patients after cardioversion (CV). In this study, we aimed to evaluate the association between vitamin D (VitD) and AF recurrence after electrical or medical CV. Method: A total of 51 patients who underwent CV for symptomatic AF were included in the study. AF recurrence was defined as an AF pattern in 12-lead electrocardiography (ECG) recording after CV within 6 months or ECG Holter recording of AF lasting more than 30 seconds at 6-month follow-up. Results: Mean vitD level was 21.4 ng/ml in our study population. VitD level was lower in the AF recurrence group than in the non-recurrence group (18 ng/ml vs. 26.3 ng/ml, respectively; P=0.001). Additionally, left atrial diameter was larger in the AF recurrence group compared to the non-recurrence group (4.4 vs. 4.1, P=0.025). Patients with AF recurrence were older than patients without AF recurrence, and, although the prevalence of hypertension is higher in the AF recurrence group, there was no statistically significant difference (P=0.107, P=0.867). Conclusion: In our study, there is a strong association between vitD level and AF recurrence after CV. VitD deficiency might be a predictor of high risk of AF recurrence after CV and vitD supplementation during the follow-up might help the maintenance of sinus rhythm.
Subject(s)
Humans , Male , Female , Middle Aged , Aged , Atrial Fibrillation , Electric Countershock , Quality of Life , Recurrence , Vitamin D , Treatment Outcome , ElectrocardiographyABSTRACT
A 61-year-old female patient with history of hipertension is scheduled to undergo a minor ginecological procedure (endoscopic endometrial polipus resection) with general anesthesia. She received standard monitorization, induction with midazolam, propofol and fentanyl. Ventilated with laringeal mask. Anesthesia was maintained with sevoflurane, nitrous oxide and oxygen. During surgical procedure, the patient received atropine and ephedrine associated with two episodes of bradycardia without hemodinamic disturbances. The surgery ended without problems. During the weaking up process she presented characteristical waves of ventricular fibrillation, recuperating sinusal rhythm secondary to defibrillation with 360 J. There was no clear cause for cardiac arrest at that moment so patient was translated to the ICU for observation, monitoring and study. Postoperative EKG presented an ascending ST segment in V to V derivations without hemodynamic alterations associated. The possible diagnosis of Brugada's Syndrome was proposed. The patient received an implantable defibrillator. The mechanisms and anesthetic implications are discussed and reviewed.
Paciente de 61 años, hipertensa, fue sometida a un procedimiento endoscópico menor (histeroscopía) bajo anestesia general balanceada. Recibió monitorización estándar, inducción con midazolam, propofol y fentanilo. Se ventiló con máscara laríngea y la mantención anestésica fue con sevoflurano asociado a NO en O. En dos oportunidades recibió atropina y efedrina para el manejo de bradicardias sin compromiso hemodinámico. Se completó el procedimiento ginecológico sin complicaciones. Durante el despertar anestésico, presentó una fibrilación ventricular que cedió con desfibrilación. Se estabilizó y trasladó a UCI donde se estudió las posibles etiologías. Se obtiene ECG postoperatorio con elevación del segmento ST en derivaciones Va V sin alteraciones hemodinámicas asociadas, postulándose un síndrome de Brugada. Se le instaló desfibrilador implantable. Se revisa y discuten los diversos mecanismos e implicancias anestésicas asociadas.
Subject(s)
Humans , Female , Middle Aged , Hysteroscopy , Anesthetics, General/administration & dosage , Brugada Syndrome/complications , Brugada Syndrome/diagnosis , Heart Arrest/etiology , Postoperative Complications , Electric Countershock , Diagnosis, Differential , Heart Arrest/therapyABSTRACT
Objetivo: avaliar a qualidade de vida de indivíduos portadores de dispositivo cardíaco eletrônico implantável. Método: estudo descritivo e transversal realizado com 50 indivíduos em 2018. Utilizou-se o SF-36 e AQUAREL. Resultados: a comorbidade mais frequente foi a hipertensão arterial sistêmica 39 (78%), a cardiopatia de base a bradicardia 18 (36%) e queixas de palpitação e pré-síncope. Predominaram indivíduos com tempo do dispositivo cardíaco eletrônico de até 5 anos 24 (48%), sem troca de gerador 31 (62%). A maioria negou o consumo de bebida alcóolica 47 (94%), de cigarros 44 (88%) e não realiza atividade física regular 34 (68%). No SF-36, o menor escore foi no domínio aspectos físicos (15) e o maior em dor (88,8). No AQUAREL o menor escore foi no domínio dispneia (78,98) e o maior em desconforto (86,54). Conclusão: constatou-se sintomatologia reduzida. Houve associação significativa entre sexo masculino e atividade física. Os indivíduos apresentam melhora da qualidade de vida após a implantação do dispositivo cardíaco.
Objective: to evaluate the quality of life of individuals with implantable electronic cardiac devices. Method: descriptive and cross-sectional study conducted with 50 individuals in 2018. SF-36 and AQUAREL were used. Results: the most frequent comorbidity was systemic arterial hypertension 39 (78%), baseline heart disease bradycardia 18 (36%) and complaints of palpitation and pre-syncope. Individuals with electronic cardiac device time of up to 5 years 24 (48%) predominated, without changing the generator 31 (62%). The majority denied alcohol consumption 47 (94%), cigarettes 44 (88%) and regular physical activity 34 (68%). In the SF-36 the lowest score was in the physical aspects domain (15) and the highest in pain (88.8). In AQUAREL the lowest score was in the domain dyspnea (78.98) and the highest in discomfort (86.54). Conclusion: reduced symptomatology was observed. There was a significant association between males and physical activity. Individuals have improved quality of life after implantation of the cardiac device.
Objetivo: evaluar la calidad de vida de las personas con dispositivos cardíacos electrónicos implantables. Método: estudio descriptivo y transversal realizado con 50 individuos, en 2018. SF-36 y AQUAREL se utilizaron. Resultados: la comorbilidad más frecuente fue la hipertensión arterial sistémica 39 (78%), las cardiopatías subyacentes, bradicardia 18 (36%) y quejas de palpitación y presíncope. Predominan los individuos con tiempo de dispositivo cardíaco electrónico de hasta 5 años 24 (48%) sin cambiar el generador 31 (62%). La mayoría negó el consumo de alcohol 47 (94%), cigarrillos 44 (88%) y actividad física regular 34 (68%). En el SF-36, la puntuación más baja estaba en el dominio de aspectos físicos (15) y la más alta en dolor (88.8). En AQUAREL, la puntuación más baja estaba en el dominio disnea (78,98) y la más alta en malestar (86,54). Conclusión: se observó una sintomatología reducida. Hubo una asociación significativa entre los varones y la actividad física. Los individuos han mejorado la calidad de vida después de la implantación del dispositivo cardíaco.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Pacemaker, Artificial , Quality of Life , Electric Countershock , Cardiac Pacing, Artificial , Cardiovascular Diseases/therapy , Cardiac Resynchronization Therapy Devices , Cardiovascular Diseases/complicationsABSTRACT
Las enfermedades cardiovasculares son una de las principales causas de mortalidad siendo los trastornos del ritmo cardiaco una de las patologías cardiacas más frecuentes. La cardioversión eléctrica es una técnica a través de la cual se realiza una transferencia de electrones al miocardio con la finalidad de interrumpir arritmias con mecanismos de reentrada permitiendo al nodo sinusal retomar el control de la frecuencia cardiaca. La correcta selección de los casos susceptibles de cardioversión eléctrica y experiencia en cardioversión aumenta la tasa de éxito y disminuye el número de choques fallidos. En el CCR- ASCARDIO, la Unidad de Electrocardiología cuenta con experiencia en el estudio y tratamiento de arritmias. En este artículo se presenta la elaboración de un programa de adiestramiento en la técnica de cardioversión eléctrica siendo esta terapia una herramienta imprescindible para la práctica clínica del cardiólogo, facilitando la prevención de complicaciones derivadas de los trastornos del ritmo cardiaco(AU)
Cardiovascular diseases are one of the main causes of mortality worldwide being heart rhythm disorders one of the most frequent cardiac pathologies. Electrical cardioversion is a technique that allows the transfer of electrons to the myocardium in order to interrupt arrhythmias with reentry mechanisms allowing the sinus node to take control of heart rate. The appropriate selection of cases susceptible to electrical cardioversion as well as experience on this technique increases the success rate and decreases the number of failed attempts. The Electrocardiology unit of the CCR-ASCARDIO has experience in the study and treatment of arrhythmias. In this article we present the development of a training program on electrical cardioversion, essential tool for cardiologists, with the aim to increase the correct use of this technique in order to prevent complications due to heart rhythm disorders(AU)
Subject(s)
Humans , Male , Female , Electric Countershock , Cardiovascular Diseases/complications , Cardiovascular Diseases/mortality , Training Courses , Arrhythmias, Cardiac/pathology , Atrial Fibrillation , Staff DevelopmentABSTRACT
Resumen La fibrilación auricular es la arritmia más frecuente en el periodo posquirúrgico de la cirugía cardíaca. Se relaciona con insuficiencia cardíaca, insuficiencia renal, embolismo sistémico y más días de estancia y mortalidad. La fibrilación auricular en el periodo posquirúrgico de la cirugía cardíaca (FAPCC) suele aparecer en las primeras 48 horas. Los principales mecanismos que producen la aparición y el mantenimiento de la FAPCC son el aumento del tono simpático y la respuesta inflamatoria. Los factores de riesgo adjuntos son la edad avanzada, enfermedad pulmonar obstructiva crónica, enfermedad renal crónica, cirugía valvular, fracción de expulsión del ventrículo izquierdo menor de 40% e interrupción de fármacos bloqueadores β. Existen instrumentos que han demostrado predecir la aparición de FAPCC. El tratamiento profiláctico con bloqueadores β y amiodarona se relaciona con disminución de la aparición de FAPCC. Dada su naturaleza transitoria, se sugiere que el tratamiento inicial de FAPCC sea el control de la frecuencia cardíaca y sólo en caso de que el tratamiento no consiga el retorno al ritmo sinusal está indicada la cardioversión eléctrica. Se desconoce cuál debe ser el seguimiento a largo plazo y sólo se conocen en escasa medida las complicaciones más allá de este periodo. La FAPCC no es una arritmia benigna ni aislada en los pacientes sometidos a operación cardíaca, por lo que la identificación de los factores de riesgo, su prevención y el seguimiento en el ámbito ambulatorio deben formar parte de las unidades dedicadas a la atención y los cuidados de estos pacientes.
Abstract Atrial fibrillation is the most frequent arrhythmia in the postoperative period of cardiac surgery. It is associated with heart failure, renal insufficiency, systemic embolism and increase in days of in-hospital and mortality. Atrial fibrillation in the postoperative period of cardiac surgery (FAPCC) usually appears in the first 48 h after surgery. The main mechanisms involved in the appearance and maintenance of FAPCC are the increase in sympathetic tone and the inflammatory response. The associated risk factors are advanced age, chronic obstructive pulmonary disease, chronic kidney disease, valve surgery, fraction of ejection of the left ventricle less 40% and the withdrawal of beta-blocker drugs. There are instruments that have been shown to predict the appearance of FAPCC. Prophylactic treatment with beta-blockers and amiodarone, is associated with a decrease in the appearance of FAPCC. Given its transient nature, it is suggested that the initial treatment of FAPCC be the heart rate control and only if the treatment does not achieve a return to sinus rhythm, the use of electrical cardioversion is suggested. It is unknown what should be the long-term follow-up and complications beyond this period are little known. FAPCC is not a benign or isolated arrhythmia in patients undergoing cardiac surgery, so the identification of risk factors, their prevention, and follow-up in the outpatient setting, should be part of the units dedicated to the care and care of these patients.
Subject(s)
Humans , Postoperative Complications/epidemiology , Atrial Fibrillation/etiology , Cardiac Surgical Procedures/methods , Atrial Fibrillation/therapy , Atrial Fibrillation/epidemiology , Electric Countershock/methods , Risk Factors , Cardiac Surgical Procedures/adverse effectsABSTRACT
Resumen La seguridad y eficacia de los anticoagulantes directos se ha demostrado como alternativas al tratamiento con antagonistas de la vitamina K en pacientes con fibrilación auricular (FA), permitiendo realizar una cardioversión precoz, especialmente en los pacientes tratados con Rivaroxabán y Edoxabán. Los pacientes con FA presentan un riesgo tromboembólico elevado, que varía según el número de factores de riesgo asociados. Además de esas características intrínsecas de cada individuo, el procedimiento de ablación puede presentar un incremento de eventos, en relación a la introducción y manipulación de catéteres, la presencia de introductores dentro de la aurícula izquierda y las lesiones endocárdicas producidas por la ablación. Por lo que es fundamental mantener la anticoagulación durante este procedimiento. Un tercer aspecto importante a tener en cuenta es el manejo perioperatorio de estos casos. El tiempo previo para suspender la terapia anticoagulante depende de cada fármaco, no se requiere puente con heparinas de bajo peso molecular y para el manejo de posibles sangrados existen algoritmos que analizaremos.
Abstract The safety and efficacy of direct anticoagulants has been demonstrated as alternatives to treatment with vitamin K antagonists in patients with atrial fibrillation (FA), allowing early cardioversion, especially in patients treated with Rivaroxaban and Edoxaban. Patients with AF have a high thromboembolic risk, which varies according to the number of associated risk factors. In addition to the intrinsic risk of each individual, the ablation procedure presents an increased risk of events, in relation to the introduction and manipulation of catheters, the presence of sheaths inside the left atrium and the endocardial lesions produced by ablation. For this reason, it is essential to maintain anticoagulation during this procedure. Finally, we present some aspects about the management in the perioperative period in this patients.